207
Participants
Start Date
March 31, 2004
Primary Completion Date
December 31, 2005
Study Completion Date
April 30, 2006
hMG
Patients with a condition
Investigational site, Elche
Investigational site, Las Palmas
Investigational site, Santiago
Investigational site, Reus
Investigational site, Albacete
Investigational site, Alicante
Investigational site, Almería
Investigational site, Barcelona
Investigational site, Burgos
Investigational site, León
Investigational site, Madrid
Investigational site, Seville
Investigational site, Toldeo
Investigational site, Valladolid
Lead Sponsor
Ferring SAU
INDUSTRY
Ferring Pharmaceuticals
INDUSTRY